Reduced IGF signaling protects against behavioral deficits, neuroinflammation and neuronal loss in a transgenic mouse model of AD and this effect was found to be associated with the sequestration of soluble, toxic oligomers [23]. The gene discussed is IGF1; the disease is Alzheimer disease.